Clinical Trial Update: Bortezomib (Velcade) in Patients With Untreated Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for bortezomib in patients with untreated multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2016-02-18